GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » PS Ratio

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) PS Ratio : 1.44 (As of May. 25, 2024)


View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, GlaxoSmithKline Consumer Nigeria's share price is ₦17.00. GlaxoSmithKline Consumer Nigeria's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was ₦11.78. Hence, GlaxoSmithKline Consumer Nigeria's PS Ratio for today is 1.44.

Warning Sign:

GlaxoSmithKline Consumer Nigeria PLC stock PS Ratio (=1.44) is close to 5-year high of 1.44

The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's PS Ratio or its related term are showing as below:

NSA:GLAXOSMITH' s PS Ratio Range Over the Past 10 Years
Min: 0.2   Med: 0.58   Max: 6.71
Current: 1.44

During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest PS Ratio was 6.71. The lowest was 0.20. And the median was 0.58.

NSA:GLAXOSMITH's PS Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.16 vs NSA:GLAXOSMITH: 1.44

GlaxoSmithKline Consumer Nigeria's Revenue per Sharefor the three months ended in Jun. 2023 was ₦3.03. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was ₦11.78.

Warning Sign:

GlaxoSmithKline Consumer Nigeria PLC revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of GlaxoSmithKline Consumer Nigeria was -17.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was -1.40% per year.

During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest 3-Year average Revenue per Share Growth Rate was 13.00% per year. The lowest was -21.00% per year. And the median was 6.80% per year.

Back to Basics: PS Ratio


GlaxoSmithKline Consumer Nigeria PS Ratio Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria PS Ratio Chart

GlaxoSmithKline Consumer Nigeria Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 0.35 0.39 0.32 0.29

GlaxoSmithKline Consumer Nigeria Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.29 0.25 0.29 0.63

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's PS Ratio

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Consumer Nigeria's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's PS Ratio distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's PS Ratio falls into.



GlaxoSmithKline Consumer Nigeria PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

GlaxoSmithKline Consumer Nigeria's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=17.00/11.78
=1.44

GlaxoSmithKline Consumer Nigeria's Share Price of today is ₦17.00.
GlaxoSmithKline Consumer Nigeria's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₦11.78.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


GlaxoSmithKline Consumer Nigeria  (NSA:GLAXOSMITH) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


GlaxoSmithKline Consumer Nigeria PS Ratio Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines